Abstract--An apparent increase in the ultrasound attenuation coefficient per unit frequency, a/, of fetal liver as a function of gestational age has been observed. Measurements were made in utero with a 25 megasample/sec RF digitizer and a real time ultrasound system with a 5 MHz scan head. A precise measurement of a/was employed in which the intercept was tied to 0 at a frequency of 0. In 178 examinations of normal pregnancies, the linear regression of the af increased 26% between 26 and 40 weeks gestation. This statistically significant increase (p < 0.0001) is consistent with several observations, those of Parker et ai. of increased attenuation in liver when glycogen is added, the increasing glycogen storage in the liver before birth, and our own pre-and postnatal measurements reported elsewhere. A noninvasive assay for glycogen content would have important applications in medicine and biomedical science. However, an increase in measurement accuracy and precise correlation with glycogen content will be required to make meaningful predictions in individual cases, as opposed to the present statistical trends.
BACKGROUND
In the summer of 1986, an apparent increased attenuation by the fetal liver as a function of gestational age was observed in early data from a study of fetal lung maturity in which liver was used as an attenuation and echogenicity comparison for the lung. Shortly after, Duerinckx et al. (1986 Duerinckx et al. ( , 1988 indicated how strongly ultrasound attenuation correlated with liver function tests in their study of adults with and without liver disease. This suggested thinking about the greatest changes, normally occurring in the liver during third trimester pregnancies and that led to consideration of the great storage of glycogen near term. If, indeed, glycogen changes were responsible for changes in ultrasound attenuation and a noninvasive assay could be developed for glycogen content in the fetus, and even children and adults, that would be quite exciting. There is no such noninvasive assay at present and most third trimester concerns involve 399 intrauterine growth retardation or other nutritional disorders. Since glycogen stores can be depleted in 12 hours of fasting or a few hours of labor and birth (Shelly 1961) , glycogen concentration should be an immediate and sensitive indicator of nutritional sufficiency. Our fetal measurements and others' measurements to verify the hypothesis of glycogen-caused variations in liver attenuation (Parker et al. 1988; Tuthill et al. 1989 ) appear promising as discussed below.
METHODS
Measurements were made in utero with an ATL Mark 100 mechanical real time system, with a 5 MHz scan head, 25 megasample/sec RF digitization, and 2-4 Mbytes of liver data per subject. The 10 mm diameter transducers in the model 420 scan head were focused at 3.2 cm and had a 6 dB bandwidth of 2.2 MHz.
The slope of the ultrasonic attenuation coefficient with frequency, or the attenuation coefficient per unit frequency, ~f, was measured by the method
A(f) = exp -(a(f)Az),
was measured from the RF signal at each frequency over a 1.7 MHz bandwidth and each location between 7.5 mm segments of tissue. Initial corrections for beam diffraction and swept gain were made by scanning a homogeneous attenuation and backscatter test object immediately after scanning the subject and with the same swept gain and other settings. The difference between the natural log of the measured power spectra from the tissue and test object is computed from the nth segment. Pairs of these quantities, separated by D segments, are subtracted, then all these difference log spectra are averaged and fit with least squares linear fit, where the resulting slope and intercept are afand a0. That is, the attenuation coefficient spectrum is:
In a few cases an attenuator setting was changed between scanning the subject and the reference test object. Theoretical diffraction corrections have been proposed and applied by numerous authors, e.g., Cloostermans and Thijssen (1983) , but these corrections have not generally worked well. This direct, experimental method should be no worse than the simple, linear theories and might correct in part for some system imperfections and physical phenomena that are not accounted for in the available theories. The test objects scanned as a reference for diffraction corrections were homogeneous attenuation test objects obtained from Radiation Measurements, Inc. Great attention was paid to obtaining the most precise and accurate estimate from the small tissue volumes accessed in the fetal lung and liver.
In the actual human subject data, rather than fitting the slope and intercept of a line to the natural log of attenuation per cm at each frequency, the intercept was fixed to zero attenuation coefficient at zero frequency. That is, a fixed value of zero was taken for a0. This gave greatly reduced variance of the attenuation coefficient slope estimate, af, on test objects (Carson and Meyer 1986) , as illustrated in Fig. 1 and Table 1 . The large, factor of 6, reduction in the SEM ofaiis consistent with the predicted ratio of the zero to nonzero intercept variances:
where f and f are the ith and mean measurement frequencies, respectively.
Unfortunately, this zero-intercept model can also reduce the reported contrast, or differences in attenuation coefficient slope of two tissue classes, when the linear, zero-intercept model is incorrect and the true slope over the limited range of measured frequencies is varying more than the attenuation coefficient divided by the frequency (Carson et al. 1988) . The literature is mixed on the issue of how good the zero-intercept hypothesis is for liver attenuation coefficient. In certain pathologies and with adequate bandwidth and sample volume, at least a two parameter linear fit is of value and a power law dependence on frequency may also be worthwhile (Lin et al. 1987; Lizzi et al. 1988; Parker et al. 1984) . In normal liver, however, a good fit is usually obtained with a linear model over the range of typical diagnostic frequencies (Goss et al. 1979; Nicholas 1982) . In fact, the zero intercept model is a good representation of normal liver for 1-8 MHz data (Lin et al. 1987) . We currently believe the statistical stability of the single-parameter, zero-intercept model warrants its use at least in normal fetal liver. Some of the confusion regarding the use of af in the zero-intercept method might be alleviated by referring in this case to aj, not as the attenuation coefficient slope, but as the attenuation coefficient divided by the measurement frequency, i.e., the attenuation coefficient per unit frequency.
Calibration and comparison measurements on several test objects are presented in Table 1 . The through transmission values in the last column of Table l were measured reproducibly in our laboratory by substitution of the test object material for water in the path between a transducer and a flat steel plate. However, that geometry, which allows inclusion of some of the forward-scattered energy, does not always provide the same result as would be obtained by an accurate attenuation measurement based purely on the change in backscattered energy with range. The means between the transmission and the nominal values (column 2) were therefore chosen as the accepted values. With this selection of accepted values af, the mean backscatter measurement ajm = 0.27 of test object B agrees closely with the accepted af= 0.26. So does the depth dependent backscatter measurement ofaj~z + afo = 0.27 if we assume that the range-dependent measurements are correct at the 4.5 cm mean range of the Regions of Interest (ROIs) in which B was measured relative to A. The three measurements of test object C, as referenced to A and B, agree as well, when the measurements are assumed correct at the mean range (5.8 cm) of those measurements. For C relative to A, aim = 0.86 and o{t:z + ajo = 0.85 and for C relative to B, aim = 0.87.
Ideally, there would be no depth dependence of the measurement of attenuation coefficient per unit frequency of one homogeneous test object relative to another. The depth dependencies observed, while rather small, indicate some failure from predictable behavior and suggest caution in analysis of the in vivo data. There may have been multiple scattering effects, small imperfections in the modeled dependence of attenuation as a function of frequency or effects of nonlinear propagation in tissue, which we were unable to demonstrate conclusively in a series of attenuation coefficient measurements by backscatter at different output settings. More likely in our commercial real time system were effects of subtle nonlinearities in the system electronics, which were not considered critical in early tests. The selection of the assumed point of zero error in the depth dependent measure- Given also for aim is the standard error of the mean (SEM). Given for the zero-intercept method only are the weighted least squares fit coefficients ofay as a function of range z in: cv= @~z + ai0, with the correction slope, asz, in dB cm -2 MHz -~. z is the mean depth of each measurement region (ROI). The value used in all further calculations is the "accepted" value, taken as the mean of the nominal value and our measured value obtained by the through transmission substitution technique. The zero-intercept1" and dual parameter:~ backscattered attenuation values were measured relative to test object A as the reference test object, at 0.58 dB cm ~ MHz -~, except in the last row, where B was employed as the reference test object. The mean range, zm, of the regions of interest for the backscatter measurements is also given. ments was appropriate for comparing the mean and the depth dependent measurements, and somewhat arbitrary for comparison of the depth dependent backscatter and accepted values of @-for test object B. Some additional confidence in the measurement technique, particularly in the relative attenuation of test objects A and B, is provided by the agreement of the backscatter measurements on test object C relative to both A and B, measured over the same depth ranges. There still remains an uncertainty of approximately 0.08 dB in the absolute attenuation coefficient slopes, which are all reported relative to either test objects A or B.
Test object B replaced A as the reference for subject studies when the gel under the entrance window of A became cracked from the repeated scanning. To prevent desiccation of the water and other volatiles in the test object, a several millimeter thick layer of fat-equivalent, mineral oil-filled block-copolymer lay just below the urethane scanning window of test object A. This layer was found to be in convex bulges, which undoubtedly varied the beam focusing depending on the location of the transducer. This caused some undefined amount of the reported variation in the data referenced to test object A.
The first 178 examinations examined by an experienced technologist with the Mark 100 system are reported. All studies were performed with informed consent of the mothers, under protocols approved by the institutional review board. To evaluate the need for possible depth corrections in the fetal liver data, depth corrections were applied based on those in Table 1 . An assumption was made that the depth dependence was linearly proportional to the relative difference between the measured fetal and the reference test object attenuation coefficients. For exampie, when the measured fetal aj-was greater than that of the reference test object A, a depth dependence was applied of
This did not consistently improve the coefficient of determination of measured fetal liver attenuation coefficient as a function of gestational age and another approach was investigated.
It has been indicated that theoretical diffraction corrections or reference test object-based diffraction corrections leave significant, unknown depth dependencies in the measured aS, unless the reference material is the same scatterer as the tissue measured (Robinson et al. 1984; Cespedes and Ophir 1989) . To determine if the corrections described above were adequate, a series of depth correction slopes, afz, was fitted to the in vivo attenuation coefficient data. These slopes were stepped in increments of 0.005 dB cm -2 MHz -~. It was assumed that the true measured attenuation coefficient slope was:
afcalc is the afwithout any further depth correction, z is the midrange of the ROI and z~0 is the range at which aj~aJc is known or assumed to be accurate. The weighted linear regression of af was calculated as a function of gestational age, with the weighting based on the experimental standard deviation of the measurements for each examination (Bevington 1969) . For the most recent, 100-case sample, the calculated coefficient of variation, R 2, was plotted in Fig. 2 as a smooth function of aj~. It is clear that R 2 is a smooth function of a/~, and we believe that selection of aj~ = 0.020 at the maximum ofR 2 provided an accurate depth correction for normal fetal liver, with measurements referenced to test object B. This maximization of R 2 essentially did the same thing as performing a weighted multivariate linear regression analysis on the same two variables, depth and gestational age. The same type of R 2 maximization plot was equally smooth for data from the 78 subjects with test object A, in which o9~ = 0.035 was found to be the appropriate correction. Subject data referenced to test objects A and B were found to have essentially the same average attenuation coefficient when Zxo = 7.0 cm, so that value was assumed for Zxo. The mean depths of the ROIs in those two subject groups, A and B, were 6.9 and 7. l cm, respectively. Thus we believe we have obtained the appropriate depth dependent correction for normal fetal liver with this specific scanhead, and possibly electronics, and have met the criteria for accurate measurements as expressed by Robinson et al. (1984) and Cespedes and Ophir (1989) . While there has been some question about the importance of the abdominal wall and other tissues overlying the organ of interest (Mountford and Wells 1972) , it is clear that maternal fat does affect the diffraction correction of a focused ultrasound beam significantly. Carpenter et al. (1988) have shown significant effects of subcutaneous fat thickness with the spheroidal hard-capsule on an end-fire scan head and we probably have similar, slightly reduced effects with the hard, cylindrical window on the ATL scanhead. In a small population, data for possible corrections for overlying tissues were obtained in the form of the thicknesses of various maternal tissue layers lying between the ultrasound transducer and the fetal lung and liver (Carson et al. 1989a (Carson et al. , 1989b . This data also had relevance to estimates of ultrasound exposures in vivo for purposes of safety evaluation. The thicknesses of the subcutaneous fat and total abdominal wall were found to correlate well with maternal weight. In unweighted, multivariate linear regressions, inclusion of maternal weight did not significantly improve the correlation of ~f with gestational age over that obtained with just the depth correction.
RESULTS
In subject group B, the attenuation coefficient slope from linear regression was: af(dB cm i MHz-l) = 0.0086(+0.0003) × AGE (wk) + 0.209(_+0.071), with R 2 = 0.26 and the F-test probability p < 0.00001 that the. slope was zero. See Fig. 3a for data acquired with reference test object B, the 0.26 dB cm -~ MHz -~ test object. Shown also are the weighted least squares fit regression line, the 95% confidence limits for that regression line and the 95% prediction limits for future data points (the outer lines). Both sets of limits assume only statistical, not systematic, errors. Data and the statistical curves are shown in Fig. 3b for the combination of studies referenced to test objects A and B. In the 78 cases referenced to test object A, the regression fit was: af(dB cm -l MHz -l) = 0.0083(+0.0002) × AGE (wk) + 0.222(+0.074), with a coefficient of determination R 2 = 0.20 and p < 0.0001. With the crossover point, Zx0, of the depth dependent attenuation chosen at 7 cm, the regression ¢. with a coefficient of determination R 2 = 0.22. Gestational age was determined from the gestational age by ultrasound at the first examination plus the difference in dates between any given ultrasound examination and the first one. Similar results were obtained from backward adjustment from the clinical estimates at the time of delivery. Analysis of af relative to abdominal circumference gave coefficients of determination which were almost as good. This is relevant, since there is some added variation in the data due to necessary reliance on separate measurements for each exam of an individual fetus and since the addition of liver glycogen is proposed as the main reason for rapid growth in abdominal circumference near term. Early analyses of the changes in aj in the serial studies on individual subjects showed similar increases with gestationai age, but did not show a dramatic reduction in variance of the increase. Fetal depths did vary over only a surprisingly small range (Carson et al. 1989b) . Multivariate analysis ofaf, as a function of gestational age and visually-determined lung echogenicity relative to liver, provided a small, but possibly insignificant increase in the coefficient of determination. Further analysis will be required to make any positive statement.
DISCUSSION
In fetal liver analyses on the same population there continues to be an increase in the attenuation coefficient of 26% over the full range of gestational ages studied, 26-40 weeks, and over the full range of abdominal circumferences. This statistically significant increase (p < 0.0001 that the slope was zero) is consistent with the change in attenuation coefficient expected from the increased glycogen content of the liver during this range ofgestational age (Shelly 1961 ) and from the measured attenuation coefficient effects of glycogen in liver (Parker et al. 1988) . Figure 4 (from Shelly) shows a rather gradual, almost linear rise in glycogen content for rhesus monkeys, the curve assumed here for humans. Sheep and dogs appear to rise more steeply to higher concentrations. A later curve measured for humans (Shelly and Neligan 1966) appears to us less reliable, because much of the prenatal data was obtained shortly after premature (Tuthill et al. 1989) .
CONCLUSIONS
Analysis of the in vivo attenuation data shows a statistically significant change in ultrasound attenuation coefficient slope by our fetal liver population with increased gestational age. The measured increase in a s by fetal livers is consistent with the hypothesis that such would be observed due to glycogen storage. However, the 26% change is not large enough to be of clinical use given the current large variance of individual measurements. The attenuation coefficient slope may well prove useful, however, when more precise measures are implemented, including: averaging of more data from independent views; using wider bandwidths; using corrections for phase aberrations by overlying tissue and improved diffraction corrections; automating the elimination of specular echoes and other inhomogeneities in the liver data; and analysis of attenuation in combination with other measures such as scatterer size and echogenicity. Liver volume may be as good as an indicator of rapid glycogen changes, but it is not measured particularly precisely at present and is an indirect measure. If glycogen changes are accompanied by a proportionate change in water content, say 2.3 parts water to one part glycogen, then unusual liver volume changes should be reasonable indicators of glycogen changes, as would occur in the onset of many cases of intrauterine growth retardation (IUGR). If glycogen storage involves very little addition of water, as suggested by the high changes in ultrasound attenuation coefficient slope reported here, then ultrasound attenuation may become the best noninvasive measure of fetal glycogen content or changes therein. A large reduction in liver attenuation coefficient recently observed between prenatal and postnatal studies in humans (Carson et al. 1989c ) is consistent with the large drop in liver solids from the depletion of glycogen associated with birth (Shelly 1961) . That observation further supports the glycogen explanation of changes in liver attenuation coefficient and modest optimism that a noninvasive ultrasound measure of glycogen content can be developed.
